Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.170
+0.080 (2.59%)
At close: Dec 5, 2025, 4:00 PM EST
3.160
-0.010 (-0.32%)
After-hours: Dec 5, 2025, 6:37 PM EST
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $247.66 million as of December 5, 2025. Its market cap has decreased by -7.50% in one year.
Market Cap
247.66M
Enterprise Value
-80.60M
1-Year Change
-7.50%
Ranking
Category
Stock Price
$3.17
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $247.66M, a decrease of -87.22%. That is a compound annual growth rate of -33.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 241.41M | -14.68% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | 3.45B | 78.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |